Phenylalanine Market Upcoming Trends, Demand, Regional Analysis and 2029 Forecast


Phenylalanine Market Drivers

An increase in the prevalence of anxiety and depression is driving up anti-depressant usage, which is driving up the global Phenylalanine Market. According to World Health Organization (WHO) figures, over 300 million people of all ages suffered from depression in 2017, with about 800,000 individuals dying by suicide as a result of anxiety disorders and depression as the primary cause. Furthermore, the National Institute of Mental Health (NIMH) estimates that in 2016, 10.3 million adults in the United States (4.3 percent of all adults in the United States) aged 18 and older experienced at least one major depressive episode with significant disability. 

According to the same source, the prevalence of major depressive disorder was higher in adult females (8.5 percent) than in males (4.8 percent ). Furthermore, the age group 18-25 had the highest rate of adults suffering from a major depressive episode (10.9 percent ). The National Institute of Mental Health (NIMH) further states that these diseases are easily curable, implying that the global Phenylalanine Market will continue to rise.

Amazing Nutrition, Inc., NOW foods, NutraMarks, health via, and Shijiazhuang Jirong Pharmaceutical Co., LiftMode (Synaptent LLC), Ltd. are some of the major participants in the phenylalanine industry.

Furthermore, over the forecast period, the rising frequency of chronic pain illnesses is expected to boost the Phenylalanine Market. According to the American Academy of Pain Medicine (AAPM), over 1.8 billion individuals worldwide suffered from chronic pain in 2011. Furthermore, according to the National Institutes of Health (NIH), one out of every ten adults in the United States suffers from chronic pain. According to a 2016 study published in the British Medical Journal, chronic pain affects about one-third to half of the population in the United Kingdom. Furthermore, around 50 million people in the United States suffer from chronic pain, according to NIH estimates published in 2015 by the American Pain Society.

Phenylalanine Market Restraints

Phenylalanine should be avoided by persons who have phenylketonuria (PKU), a genetic condition in which the body accumulates too much phenylalanine. If people with phenylketonuria take phenylalanine, they can develop mental retardation, high blood pressure, stroke, and a variety of other serious health problems. PKU is a serious disorder for which infants are usually examined at birth to see if they have it and will require a particular diet to avoid complications.

Comments

Popular posts from this blog

Endometrial Ablation Market Analysis, Industry Scope, Global Opportunity Analysis and Forecast Till 2027

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Artificial Intelligence And Machine Learning Are Fueling Growth Of Assessment Services Market